Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Marina Pisano"'
Autor:
Paolo A. Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Virginia Ferraresi, Ana Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbe, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F. Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero, Antonio M. Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract No prospective data were available prior to 2021 to inform selection between combination BRAF and MEK inhibition versus dual blockade of programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte antigen-4 (CTLA-4) as first-line treat
Externí odkaz:
https://doaj.org/article/2b98c18ea9d84e45baec87cc1752497f
Autor:
Andrea Anichini, Alessandra Molla, Gabriella Nicolini, Valentina Eleonora Perotti, Francesco Sgambelluri, Alessia Covre, Carolina Fazio, Maria Fortunata Lofiego, Anna Maria Di Giacomo, Sandra Coral, Antonella Manca, Maria Cristina Sini, Marina Pisano, Teresa Noviello, Francesca Caruso, Silvia Brich, Giancarlo Pruneri, Andrea Maurichi, Mario Santinami, Michele Ceccarelli, Giuseppe Palmieri, Michele Maio, Roberta Mortarini, On behalf of the EPigenetic Immune-oncology Consortium AIRC (EPICA) investigators
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-15 (2022)
Abstract Background Improvement of efficacy of immune checkpoint blockade (ICB) remains a major clinical goal. Association of ICB with immunomodulatory epigenetic drugs is an option. However, epigenetic inhibitors show a heterogeneous landscape of ac
Externí odkaz:
https://doaj.org/article/79c74f16caf34f389f373906c070b84d
Autor:
Panagiotis Paliogiannis, Maria Colombino, Maria Cristina Sini, Antonella Manca, Milena Casula, Grazia Palomba, Marina Pisano, Valentina Doneddu, Angelo Zinellu, Davide Santeufemia, Sardinian Lung Cancer (SLC) Study Group, Giovanni Sotgiu, Antonio Cossu, Giuseppe Palmieri
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Advanced lung adenocarcinoma (LAC) is one of the most lethal malignancies worldwide. The aim of this study was to evaluate the global survival in a real-life cohort of patients with LAC harboring driver genetic alterations. Method
Externí odkaz:
https://doaj.org/article/7029413aa581422290dbd6c1d3035618
Autor:
Milena Casula, Marina Pisano, Panagiotis Paliogiannis, Maria Colombino, Maria Cristina Sini, Angelo Zinellu, Davide Santeufemia, Antonella Manca, Stefania Casula, Silvia Tore, Renato Lobrano, Sardinian Lung Cancer Study Group, Antonio Cossu, Giuseppe Palmieri
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6410 (2023)
Oncogenic mutations in the EGFR gene are targets of tyrosine kinase inhibitors (TKIs) in lung adenocarcinoma (LC) patients, and their search is mandatory to make decisions on treatment strategies. Liquid biopsy of circulating tumour DNA (ctDNA) is in
Externí odkaz:
https://doaj.org/article/6f6aa67f5fd84ad4909f747f352214a1
Autor:
Stefano Mariani, Marco Puzzoni, Riccardo Giampieri, Pina Ziranu, Valeria Pusceddu, Clelia Donisi, Mara Persano, Giovanna Pinna, Erika Cimbro, Alissa Parrino, Dario Spanu, Andrea Pretta, Eleonora Lai, Nicole Liscia, Alessio Lupi, Enrica Giglio, Grazia Palomba, Milena Casula, Marina Pisano, Giuseppe Palmieri, Mario Scartozzi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundRechallenge with EGFR inhibitors represents a promising strategy for patients with RAS wild type (WT) colorectal cancer (CRC) but definitive selection criteria are lacking. Recently, the RAS WT status on circulating tumor DNA (ct-DNA) emerg
Externí odkaz:
https://doaj.org/article/7c74f9145f1d405983f83568cd2f0eab
Autor:
Irene Vanni, Milena Casula, Lorenza Pastorino, Antonella Manca, Bruna Dalmasso, Virginia Andreotti, Marina Pisano, Maria Colombino, Italian Association for Cancer Research (AIRC) Study Group, Ulrich Pfeffer, Enrica Teresa Tanda, Carla Rozzo, Panagiotis Paliogiannis, Antonio Cossu, Paola Ghiorzo, Giuseppe Palmieri, for the Italian Melanoma Intergroup (IMI)
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-18 (2020)
Abstract Background Identification of somatic mutations in key oncogenes in melanoma is important to lead the effective and efficient use of personalized anticancer treatment. Conventional methods focus on few genes per run and, therefore, are unable
Externí odkaz:
https://doaj.org/article/69d423c7d1ab4b458a345ad25ac7c05f
Autor:
Maria Colombino, Panagiotis Paliogiannis, Antonio Cossu, Davide Adriano Santeufemia, Sardinian Lung Cancer (SLC) Study Group, Maria Cristina Sini, Milena Casula, Grazia Palomba, Antonella Manca, Marina Pisano, Valentina Doneddu, Giuseppe Palmieri
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Lung cancer is one of the most incident neoplastic diseases, and a leading cause of death for cancer worldwide. Knowledge of the incidence of druggable genetic alterations, their correlation with clinical and pathological features
Externí odkaz:
https://doaj.org/article/3808da9778ab4b348f68f7a3009138c9
Autor:
Gaia Rocchitta, Carla Rozzo, Marina Pisano, Davide Fabbri, Maria Antonietta Dettori, Paolo Ruzza, Claudia Honisch, Roberto Dallocchio, Alessandro Dessì, Rossana Migheli, PierAndrea Serra, Giovanna Delogu
Publikováno v:
Molecules, Vol 27, Iss 22, p 7942 (2022)
Tyrosinase is a well-known copper-containing metalloenzyme typically involved in the synthesis of melanin. Recently, curcumin and several synthetic derivatives have been recognized as tyrosinase inhibitors with interesting anti-melanogenic therapeuti
Externí odkaz:
https://doaj.org/article/f9ba52cca3de45669dd6e8b3582376c5
Autor:
Giovanni M. Fadda, Renato Lobrano, Milena Casula, Marina Pisano, Antonio Pazzola, Antonio Cossu, Giuseppe Palmieri, Panagiotis Paliogiannis
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 11, p 1874 (2022)
Lung cancer is one of the most common and lethal cancers worldwide. Numerous medications targeting specific molecular alterations in non-small cell lung cancer have been introduced in the last decade and have revolutionized the clinical management of
Externí odkaz:
https://doaj.org/article/790b92a242424c258bd203ce69b8c12d
Autor:
Giuseppe Palmieri, Carla Maria Rozzo, Maria Colombino, Milena Casula, Maria Cristina Sini, Antonella Manca, Marina Pisano, Valentina Doneddu, Panagiotis Paliogiannis, Antonio Cossu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The improvement of the immunotherapeutic potential in most human cancers, including melanoma, requires the identification of increasingly detailed molecular features underlying the tumor immune responsiveness and acting as disease-associated biomarke
Externí odkaz:
https://doaj.org/article/3799cd5e653b4df6aa576f4affd3e2dd